In Vivo Detection of Circulating Clots in Patients With Thromboembolism
Recruiting now · Not applicable
Conditions studied: Thromboembolism
In brief
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
Key facts
- Study ID
- NCT05301348
- Run by
- University of Arkansas
- People needed
- 30
- Starts
- 2023-07-26
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2026-02-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women, 18 years old and older.
- Evidence of current venous or arterial thromboembolic disease diagnosed by standard of care clinical, radiographic, or laboratory testing or acute ischemic stroke.
- Informed consent provided by the subject.
You may not qualify if…
- Pulmonary embolus with a need for mechanical ventilation or other ventilator support (may be on oxygen delivered by nasal cannula or mask at an FiO2 of ≤ 0.40)
- Acute coronary syndrome (including unstable angina)
- Significant cardiac arrhythmia (may have atrial fibrillation controlled with medication)
- Intracardiac thrombus
- Any embolus or thrombus requiring vascular surgery or interventional radiology to attempt acute embolectomy or thrombectomy
- Sickle cell disease with vaso-occlusive crisis
- Sepsis or life-threatening infection
- Traumatic injury requiring hospitalization (within 30 days prior to enrollment)
- Pregnancy or breastfeeding
- Severe mental illness
- Other conditions deemed by the investigators to put the subject at greater risk
Where it is running
- Univerisity of Arkansas for Medical Sciences — Little Rock, Arkansas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.